These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26330171)

  • 1. Advances in Neurotrophic Factor and Cell-Based Therapies for Parkinson's Disease: A Mini-Review.
    Staudt MD; Di Sebastiano AR; Xu H; Jog M; Schmid S; Foster P; Hebb MO
    Gerontology; 2016; 62(3):371-80. PubMed ID: 26330171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of the endoplasmic reticulum located and secreted CDNF/MANF family of neurotrophic factors in Parkinson's disease.
    Voutilainen MH; Arumäe U; Airavaara M; Saarma M
    FEBS Lett; 2015 Dec; 589(24 Pt A):3739-48. PubMed ID: 26450777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral vector delivery of neurotrophic factors for Parkinson's disease therapy.
    Kelly MJ; O'Keeffe GW; Sullivan AM
    Expert Rev Mol Med; 2015 May; 17():e8. PubMed ID: 25997719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cells therapy for Parkinson's disease--so close and so far away.
    Ren Z; Zhang Y
    Sci China C Life Sci; 2009 Jul; 52(7):610-4. PubMed ID: 19641865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotrophic factor therapy for Parkinson's disease.
    Rangasamy SB; Soderstrom K; Bakay RA; Kordower JH
    Prog Brain Res; 2010; 184():237-64. PubMed ID: 20887879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects of Neurotrophic Factors for Parkinson's Disease: Comparison of Protein and Gene Therapy.
    Domanskyi A; Saarma M; Airavaara M
    Hum Gene Ther; 2015 Aug; 26(8):550-9. PubMed ID: 26176331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cell therapy for Parkinson's disease].
    Morizane A; Takahashi J
    Nihon Yakurigaku Zasshi; 2016 May; 147(5):264-8. PubMed ID: 27181719
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuronal transplantation and neurotrophic factors in the treatment of Parkinson's disease--update February 1995.
    Kupsch A; Oertel WH; Earl CD; Sautter J
    J Neural Transm Suppl; 1995; 46():193-207. PubMed ID: 8821056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AAV2-neurturin (CERE-120) for Parkinson's disease.
    Hickey P; Stacy M
    Expert Opin Biol Ther; 2013 Jan; 13(1):137-45. PubMed ID: 23228025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future and current surgical therapies in Parkinson's disease.
    Betchen SA; Kaplitt M
    Curr Opin Neurol; 2003 Aug; 16(4):487-93. PubMed ID: 12869808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotrophic factors as a therapeutic target for Parkinson's disease.
    Evans JR; Barker RA
    Expert Opin Ther Targets; 2008 Apr; 12(4):437-47. PubMed ID: 18348680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repairing the parkinsonian brain with neurotrophic factors.
    Aron L; Klein R
    Trends Neurosci; 2011 Feb; 34(2):88-100. PubMed ID: 21144600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.
    Lindsay RM; Altar CA; Cedarbaum JM; Hyman C; Wiegand SJ
    Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug development in Parkinson's disease: from emerging molecules to innovative drug delivery systems.
    Garbayo E; Ansorena E; Blanco-Prieto MJ
    Maturitas; 2013 Nov; 76(3):272-8. PubMed ID: 23827471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
    Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease.
    Sadan O; Bahat-Stromza M; Barhum Y; Levy YS; Pisnevsky A; Peretz H; Ilan AB; Bulvik S; Shemesh N; Krepel D; Cohen Y; Melamed E; Offen D
    Stem Cells Dev; 2009 Oct; 18(8):1179-90. PubMed ID: 19243240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cells may reshape the prospect of Parkinson's disease therapy.
    Sonntag KC; Simantov R; Isacson O
    Brain Res Mol Brain Res; 2005 Mar; 134(1):34-51. PubMed ID: 15790528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Researchers broaden the attack on Parkinson's disease.
    Barinapa M
    Science; 1995 Jan; 267(5197):455-6. PubMed ID: 7824944
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell Therapy for Parkinson's Disease.
    Morizane A; Takahashi J
    Neurol Med Chir (Tokyo); 2016; 56(3):102-9. PubMed ID: 26912295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging restorative treatments for Parkinson's disease.
    Deierborg T; Soulet D; Roybon L; Hall V; Brundin P
    Prog Neurobiol; 2008 Aug; 85(4):407-32. PubMed ID: 18586376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.